Medtronic (MDT) Tops Q3 EPS by 2c; offers guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mail
Get Alerts MDT Hot Sheet
Price: $104.96 +6.15%
EPS Growth %: -2.2%
Financial Fact:
Research and development expense: 373M
Today's EPS Names:
COHR, ATS, SICP, More
EPS Growth %: -2.2%
Financial Fact:
Research and development expense: 373M
Today's EPS Names:
COHR, ATS, SICP, More
Join SI Premium – FREE
Medtronic (NYSE: MDT) reported Q3 EPS of $1.36, $0.02 better than the analyst estimate of $1.34. Revenue for the quarter came in at $9 billion versus the consensus estimate of $8.91 billion.
GUIDANCE:
Medtronic sees FY2026 EPS of $5.62-$5.66, versus the consensus of $5.65.
For earnings history and earnings-related data on Medtronic (MDT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Myriad Genetics (MYGN) Tops Q3 EPS by 9c ; Offers Guidance
- Enact Holdings (ACT) Reports In-Line Q3 EPS
- Array Technologies Inc. (ARRY) Misses Q3 EPS by 3c ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
